Internal Medicine, Rheumatology · Peoria, AZ
NPI
1174512263
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
13943 N. 91st Ave, Building I
Peoria, AZ, 85381
Phone (623) 815-2690
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.3M
231,604 services
Medicare patients, 2024
1,048
Average age 75
Drug cost, 2024
$5.7M
17,047 prescriptions
Company payments, 2025
$2,294
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ravi Bhalla was code J3262 (injection, tocilizumab, 1 mg), 93,260 times for 21 patients. In total Ravi Bhalla billed 231,604 services in 47 codes, and Medicare paid $3.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-06-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 93,260 | 21 | $4.71 | $439K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 26,350 | 43 | $33.23 | $876K |
| J0897 Injection, denosumab, 1 mg | Office | 24,780 | 248 | $20.35 | $504K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 24,450 | 29 | $9.07 | $222K |
| J0490 Injection, belimumab, 10 mg | Office | 7,712 | 11 | $39.25 | $303K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 6,530 | 31 | $24.14 | $158K |
| J9312 Injection, rituximab, 10 mg | Office | 3,605 | 13 | $54.46 | $196K |
| 99214 Office E&M - Established | Office | 1,760 | 806 | $80.55 | $142K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,516 | 784 | $10.77 | $16K |
| 96372 Injection Administration | Office | 976 | 336 | $9.68 | $9,451 |
| 96375 Injection Administration | Office | 896 | 136 | $10.63 | $9,523 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 882 | 135 | $0.63 | $558 |
| 96365 Intravenous Infusion, Hydration | Office | 837 | 127 | $44.01 | $37K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 734 | 129 | $0.72 | $530 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 721 | 12 | $0.23 | $164 |
By year: 2022 $3.2M for 248,303 services; 2023 $3.2M for 239,433 services; 2024 $3.3M for 231,604 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ravi Bhalla prescribed most often to Medicare patients was Prednisone, with 2,205 prescriptions and refills. In total Ravi Bhalla wrote 17,047 Medicare prescriptions that cost $5.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 2,205 | 3,402 | 545 | $14K |
| Hydroxychloroquine Sulfate Generic | 1,756 | 3,338 | 449 | $77K |
| Methotrexate Methotrexate Sodium | 1,390 | 2,556 | 324 | $27K |
| Pregabalin Generic | 914 | 1,097 | 184 | $17K |
| Gabapentin Generic | 851 | 1,462 | 196 | $14K |
| Tramadol Hcl Generic | 842 | 842 | 142 | $5,801 |
| Duloxetine Hcl Generic | 770 | 1,353 | 168 | $13K |
| Tizanidine Hcl Generic | 664 | 1,143 | 196 | $7,395 |
| Baclofen Generic | 494 | 806 | 134 | $8,243 |
| Leflunomide Generic | 437 | 874 | 101 | $21K |
| Celecoxib Generic | 424 | 717 | 93 | $11K |
| Azathioprine Generic | 387 | 734 | 96 | $19K |
| Methylprednisolone Generic | 371 | 471 | 149 | $6,135 |
| Alendronate Sodium Generic | 332 | 656 | 97 | $2,432 |
| Allopurinol Generic | 308 | 750 | 78 | $3,340 |
Brand drugs: 1,519 claims; generic drugs: 15,516 claims; opioid claims: 924.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ravi Bhalla $2,294 ($2,294 in general payments such as food, travel and fees) from 19 companies. The largest payer was Amgen Inc. with $734.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 45 | $734 |
| Abbvie Inc. ABBV | 35 | $713 |
| UCB, Inc. UCB.BR | 7 | $197 |
| Medtronic, Inc. MDT | 1 | $130 |
| GlaxoSmithKline, LLC. GSK | 4 | $74.91 |
| Radius Health, Inc. | 3 | $65.85 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $60.39 |
| Aurinia Pharma U.S., Inc. AUPH | 2 | $46.64 |
| Fresenius Kabi USA, LLC | 2 | $42.12 |
| Genentech USA, Inc. ROG.SW | 2 | $37.01 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.